Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases $133,041.84 in Stock

Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) major shareholder Saba Capital Management, L.P. bought 9,704 shares of the firm’s stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $13.71 per share, with a total value of $133,041.84. Following the transaction, the insider now directly owns […]

Related Keywords

,Securities Exchange Commission ,Karpus Management Inc ,Abrdn Life Sciences Investors Increases Dividend ,Institutional Trading Of Abrdn Life Sciences Investors ,Abrdn Life Sciences Investors Stock ,Advisors Asset Management Inc ,Cetera Advisors ,B Riley Wealth Advisors Inc ,Quarter For Abrdn Life Sciences Investors ,Abrdn Life Sciences Investors ,Get Free Report ,Saba Capital Management ,Exchange Commission ,Capital Management ,Life Sciences Investors ,Abrdn Life Sciences ,Investment Advisers ,Riley Wealth Advisors ,Asset Management ,Karpus Management ,Inc The ,Abrdn Life Sciences Investors Daily ,